Expression of tumor suppressor and tumor-related proteins in differentiated carcinoma, undifferentiated carcinoma with tubular component and pure undifferentiated carcinoma of the stomach

Japanese Journal of Clinical Oncology

Volumn 35, Issue 10, 2005, Pages 580-586

  Honda, Teiichiro ^a   Tamura, Gen ^a,d   Endoh, Yasushi ^b   Nishizuka, Satoshi ^c   Kawata, Sumio ^a   Motoyama, Teiichi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b Department of Radiology   (Japan)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NONE   (Japan)

Author keywords

Gastric cancer; Immunohistochemistry; Tissue microarray

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FORMALDEHYDE; PARAFFIN; PROTEIN MLH1; PROTEIN P16; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STOMACH CARCINOMA; TISSUE DISTRIBUTION; TISSUE MICROARRAY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NUCLEAR PROTEINS; PROTEIN ARRAY ANALYSIS; RECEPTOR, ERBB-2; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 27944493981     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyi166     Document Type: Article

References (38)

1. Golub RT, Slonim KD, Tamayo P, Huard C, Gaasenbeek M, Mesirov PJ, et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 1999;286:531-53.
2. Perou CM, Sorlie T, Elsen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumors. Nature 2000;406:747-52.
3. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang HC, Angelo M, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 2001;98:15149-54.
4. Kononen J, Bubendorf L, Kalhoniemi A, Barlund M, Schrami P, Leighton S, et al. Tissue microarray for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-7.
5. Henshall S. Tissue microarrays. J Mammary Gland Biol Neoplasia 2003;8:347-58.
6. Shergill IS, Shergill NK, Arya M, Patel HRH. Tissue microarrays: A current medical research tool. Curr Med Res Opin 2004;20:707-12.
7. van de Rijn M, Gilks CB. Applications of microarrays to histopathology. Histopathology 2004;44:97-108.
8. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours. 6th edn. New York: Wiley-Liss 2002.
9. Tatematsu M, Hasegawa R, Ogawa K, Kato T, Ichinose M, Miki K, Ito N. Histogenesis of human stomach cancers based on assessment of differentiation. J Clin Gastroenterol 1992;14:S1-7.
10. Williamson M, Naaby-Hansen S, Masters JRW. 21st century molecular biology in urology. BJU Int 2001;88:451-7.
11. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal type carcinoma. An attempt at a histological classification. Acta Pathol Microbiol Scand 1965;64:31-49.
12. Nakamura K, Sugano H, Takagi K. Carcinoma of the stomach in incipient phase: Its histogenesis and histological appearances. Gann 1968;59:251-8.
13. Tamura G. Promoter methylation status of tumor suppressor and tumor-related genes in neoplastic and nonneoplastic gastric epithelia. Histol Histopathol 2004;19:221-8.
14. Tahara E. Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis. Cancer 1995;75:1410-7.
15. Rimm DL, Camp RL, Charette LA, Olsen DA, Provost E. Amplification of tissue by construction of tissue microarrays. Exp Mol Pathol 2001;70:255-64.
16. Mousses S, Kallioniemi A, Kauraniemi P, Elkahloun A, Kallioniemi OP. Clinical and functional target validation using tissue and cell microarrays. Curr Opin Chem Biol 2001;6:97-101.
17. Brandt B, Roetger A, Bidart JM, Packeisen J, Schier K, Mikesch JH, et al. Early placenta insulin-like growth factor (proEPIL) is overexpressed and secreted by c-erbB-2-positive cells with high invasion potential. Cancer Res 2002;62:1020-4.
18. Rubin MA, Dunn R, Strawderman M, Pienta KJ. Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol 2002;26:313-9.
19. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000;80:1943-9.
20. Peng DF, Sugihara H, Mukaisho K, Ling ZQ, Hattori T. Genetic lineage of poorly differentiated gastric carcinoma with a tubular component analysed by comparative genomic hybridization. J Pathol 2004;203:884-95.
21. Tamura G, Sato K, Akiyama S, Tsuchiya T, Endoh Y, Usuba O, et al. Molecular characterization of undifferentiated-type gastric carcinoma. Lab Invest 2001;81:593-8.
22. Tamura G, Sakata K, Maesawa C, Suzuki Y, Terashima M, Satoh K, et al. Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach. Cancer Res 1995;55:1933-6.
23. Monig SP, Eidt S, Zirbes TK, Stippel D, Baldus SE, Pichlmaier H. p53 expression in gastric cancer. Dig Dis Sci 1997;42:2463-7.
24. Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S. p53 mutatMon in gastric cancer: A genetic: model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer 1993;54:759-64.
25. Feakins RM, Nickols CD, Bidd H, Walton SJ. Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: Relationship with pathological features and survival. Hum Pathol 2003;34:1276-82.
26. Osawa T, Chong JM, Sudo M, Sakuma K, Uozaki H, Shibahara J, et al. Reduced expression and promoter methylation of p16 gene in Epstein-Barr virus-associated gastric carcinoma. Jpn J Cancer Res 2002;93:1195-200.
27. Shim YH, Kang GH, Ro JY. Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas. Lab Invest 2000;80: 689-95.
28. Waki T, Tamura G, Tsuchiya T, Sato K, Nishizuka S, Motoyama T. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am J Pathol 2002;161:399-403.
29. Tsujimoto H, Hagiwara A, Sugihara H, Hattori T, Yamagishi H. Promoter methylations of p16INK4a and p14ARF genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type. Pathol Res Pract 2002;198:785-94.
30. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998;95:6870-5.
31. Fleisher AS, Esteller M, Wang S, Tamura G, Suzuki H, Yin J, et al. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 1999;59:1090-5.
32. Guo RJ, Arai H, Kitayama Y, Igarashi H, Hemmi H, Arai T, et al. Microsatellite instability of papillary subtype of human gastric adenocarcinoma and hMLH1 promoter hypermethylation in the surrounding mucosa. Pathol Int 2001;51:240-7.
33. Endoh Y, Tamura G, Ajioka Y, Watanabe H, Motoyama T. Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype. Am J Pathol 2000;157:717-22.
34. Nakajima T, Akiyama Y, Shiraishi J, Arai T, Yanagisawa Y, Ara M, et al. Age-related hypermethylation of the hMLH1 promoter in gastric cancers. Int J Cancer 2001;94:208-11.
35. Mizutani T, Onda M, Tokunaga A, Yamanaka N, Sugisaki Y. Relationship of c-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer. Cancer 1993;72:2083-8.
36. Polkowski W, van Sandick JW, Offerhaus GJ, ten Kate FJ, Mulder J, Obertop H, van Lanschot JJ. Prognostic value of Lauren classification and c-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol 1999;6:290-7.
37. Uchino S, Tsuda H, Maruyama K, Kinoshita T, Sasako M, Saito T, et al. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients. Cancer 1993;72:3179-84.
38. Wittekind C, Wachner R, Henke W, Von Kleist S. Localization of CEA, HCG, lysozyme, alpha-1-antitrypsin, and alpha-1-antichymotrypsin in gastric cancer and prognosis. Virchows Arch A Pathol Anat Histopathol 1986;409:715-24.